Close Menu

Golden Helix

New Products: May 17, 2011


Golden Helix's SNP and Variation Suite, RefSeq Release 47, Convey Computer's Convey GraphConstructor

While the firm's customers will be able to use the module to conduct tertiary analysis of next-generation DNA-sequencing data, the tool could also benefit array users, particularly those using high-density chips in association studies.

The new module, which will provide an integrated desktop tool for tertiary analysis of next-generation DNA sequencing data, is the company's first for the NGS sector.

The company said that the next version of its SNP & Variation Suite software will be able to run on off-the-shelf GPUs and detect copy number variations 10 to 20 times faster on a GPU than on a similarly priced CPU.

New Products: Oct 26, 2010


Life Technologies' Exact Call Chemistry probe for SOLiD, Caliper's LabChip GX assay and Sciclone NGS Workstation, Adaptive TCR's immunoSEQ, Golden Helix's SNP and Variation Suite, GenBank 180.0

Vancouver, Canada-based Sirius Genomics is using arrays to develop a test to identify individuals who respond to the hormone vasopressin and similar compounds for the treatment of septic shock.

The two firms will partner to develop diagnostics to identify individuals who respond well to Vasopressin and other compounds for the treatment of septic shock and related conditions.

Golden Helix is working with Harvard to rewrite the code for an informatics tool for studying disease heritability in families.

Golden Helix's SNP and Variation software suite contains modules for copy-number analysis, whole-genome analysis, and regression, among others, which together enable researchers to manage and analyze genetic data.

CloudScientific will distribute Golden Helix's analytical services and proprietary software in China.


A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.